Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway

Journal of Neuroendocrinology

Volumn 12, Issue 3, 2000, Pages 191-197

  Bailey, Alex R T ^b,c   Von Englehardt, N ^b   Leng, G ^b   Smith, R G ^a,b   Dickson, S L ^b  

^a Huffington Center on Aging   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Area postrema; GHRP 6; Growth hormone secretagogues; Noradrenaline

Indexed keywords

GROWTH HORMONE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; IBUTAMOREN; NEUROTOXIN; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; AREA POSTREMA; ARTICLE; BRAIN NERVE CELL; BRAIN STEM; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HYPOTHALAMUS; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

ANIMALS; ARCUATE NUCLEUS; BRAIN STEM; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; INDOLES; MALE; NEUROTOXINS; OLIGOPEPTIDES; PHENETHYLAMINES; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPIRO COMPOUNDS; TYROSINE 3-MONOOXYGENASE;

EID: 0034060310     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00398.x     Document Type: Article

References (31)

1. Ghigo E, Arvat E, Mucciolo G, Camanni F. Growth hormone-releasing peptides. Eur J Endocrinol 1997; 136: 445-460.
2. Smith RG, Van Der Ploeg LHT, Howard AD, Feighner SD, Cheng K, Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DBR, Cheng K, Hickey G, Wyvratt MJ, Fisher MH, Nargund RP, Patchett AA. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997; 18: 621-645.
3. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984; 114: 1537-1545.
4. Dickson SL, Leng G, Robinson ICAF. Systemic administration of growth hormone-releasing peptide (GHRP-6) activates hypothalamic arcuate neurones. Neuroscience 1993; 53: 303-306.
5. Bailey ART, Smith RG, Leng G. The non-peptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurones in vivo. J Neuroendocrinol 1998; 10: 111-118.
6. Dickson SL, Leng G, Dyball REJ, Smith RG. Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology 1995; 61: 36-43.
7. Dickson SL, Luckman SM. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997; 138: 771-777.
8. Kamegai J, Hasegawa O, Minami S, Sugihara H, Wakabayashi I. The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus. Mol Brain Res 1996; 39: 153-159.
9. Merchenthaler I. Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with Fluorogold. Neuroscience 1991; 44: 655-662.
10. Ferguson AV, Bains JS. Electrophysiology of the circumventricular organs. Front Neuroendocrinol 1996; 17: 440-475.
11. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993; 7: 678-686.
12. Hamamura M, Nunez DJ, Leng G, Emson PC, Kiyama H. C-fos may code for a common transcription factor within the hypothalamic neural circuits involved in osmoregulation. Brain Res 1992; 572: 42-51.
13. Borison HL. Area postrema: chemoceptor trigger zone for vomiting is that all? Life Sci 1974; 14: 1807-1817.
14. Sawchenko PE, Swanson LW. Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 1981; 214: 685-687.
15. Day TA, Sibbald JR. Direct catecholaminergic projection from the nucleus tractus solitarius to supraoptic nucleus. Brain Res 1988; 454: 387-392.
16. Onaka T, Luckman SM, Antonijevic I, Palmer JR, Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarius to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience 1995; 66: 403-412.
17. Al-Damlugi S. Adrenergic control of the secretion of anterior pituitary hormones. Ballieres Clin Endocrinol Metab 1993; 7: 355-392.
18. Willoughby JO, Chapman IA, Kapnoor R. Local hypothalamic adrenoceptor activation in rat: α1 inhibits and α2 stimulates growth hormone secretion. Neuroendocrinology 1993; 57: 687-692.
19. Makara GB, Kiem DT, Vizi ES. Hypothalamic alpha-2A adrenoceptors stimulate growth hormone release in the rat. Eur J Pharmacol 1995; 287: 43-48.
20. Sawchenko PE, Swanson LW. Central noradrenergic pathways for the integration of neuroendocrine and autonomic responses. Science 1981; 214: 685-687.
21. McCormick GF, Millard WJ, Badger TM, Bowers CY, Martin JB. Dose response characteristics of various peptides with growth hormone-releasing activity in the unanesthetized male rat. Endocrinology 1985; 117: 97-105.
22. Grass P, Jaquet P, Jervell J, Kendall-Taylor P, Lamberts SW, Marbach P, Orskov H, Pagani G, Sheppard M, Simionescu L, Sandostatin LAR. a promising therapeutic tool in the management of acromegalic patients. Metab Clin Exp 1996; 45: 67-71.
23. Dickson SL, Viltart O, Bailey ART, Leng G. Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action. Neuroendocrinology 1997; 66: 188-194.
24. Zheng H, Bailey ART, Jiang M, Honda K, Chen HY, Trumbauer ME, Van der Ploeg LHT, Schaeffer JM, Leng G, Smith RG. Somatostatin receptor subtype-2 knockout mice are refractory to growth hormone negative feedback on arcuate neurones. Mol Endocrinol 1997; 11: 1709-1717.
25. Frieboes RM, Murck H, Maier P, Scier T, Holsboer F, Steiger A. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in man. Neuroendocrinology 1995; 61: 584-589.
26. Thomas GB, Fairhall KM, Robinson ICAF. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 1997; 138: 1585-1591.
27. Locke W, Kirgis HD, Bowers CY, Abdo AA. Intracerebroventricular growth hormone-releasing peptide-6 stimulates eating with affecting plasma growth hormone responses in rats. Life Sci 1995; 56: 1347-1352.
28. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T, Wakabayashi I. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 1996; 137: 5155-5158.
29. Miller AD, Leslie RA. The area postrema and vomiting. Front Neuroendocrinol 1994; 15: 301-320.
30. Dockray GJ. The gut endocrine system and its control. Exp Physiol 1994; 79: 607-634.
31. Herman JP, Prewitt CM, Cullinan WE. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical axis. Crit Rev Neurobiol 1996; 10: 371-394.